What is uniQure's cash & equivalents?

uniQure (QURE) reported cash & equivalents of $139.99M in Q1 2026.

How has uniQure's cash & equivalents changed year-over-year?

uniQure's cash & equivalents decreased by 35.6% year-over-year, from $217.23M to $139.99M.

What is the long-term trend for uniQure's cash & equivalents?

Over 5 years (2020 to 2025), uniQure's cash & equivalents has grown at a -20.0% compound annual growth rate (CAGR), from $244.93M to $80.24M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

uniQure QURE Cash & Equivalents

Cash & Equivalents at other companies

Sarepta Therapeutics, Inc.SRPT

$464.45M+92.8%

Taysha Gene Therapies, Inc.TSHA

$276.58M+137%

Denali Therapeutics Inc.DNLI

$390.73M+551%

Stoke Therapeutics, Inc.STOK

$155.66M-43.4%

PrecigenPGEN

$7.48M+23.5%

PTC TherapeuticsPTCT

$833.99M-43.7%

Other financials

Income statement

See full

Revenue$3.6M+127%

Gross profit$3.3M+144%

Operating income-$45.7M-16.2%

Net income-$53.5M-22.7%

EPS (diluted)-$0.85-3.7%

Balance sheet

See full

Total debt$63.3M-4.3%

Total equity$149.3M+343%

Total assets$778.7M+28.6%

Cash flow

See full

Operating cash flow-$38.2M+13.3%

CapEx$140.0K+11.1%

Free cash flow-$38.4M+13.2%

Valuation

See full

Market cap$3.09B+78.4%

Enterprise value$3.02B+124%

P/S170.9×+85.1×

Profitability

See full

Gross margin90.6%-2.9pp

Operating margin-1,059.7%+380pp

Net margin-1,154.4%+89.3pp

FCF margin-953.7%+169pp

Returns & leverage

See full

Return on equity-228.2%-11.6pp

Debt / equity0.4×-1.5×

Current ratio10.4×-1.6×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is uniQure's cash & equivalents?: uniQure (QURE) reported cash & equivalents of $139.99M in Q1 2026.
How has uniQure's cash & equivalents changed year-over-year?: uniQure's cash & equivalents decreased by 35.6% year-over-year, from $217.23M to $139.99M.
What is the long-term trend for uniQure's cash & equivalents?: Over 5 years (2020 to 2025), uniQure's cash & equivalents has grown at a -20.0% compound annual growth rate (CAGR), from $244.93M to $80.24M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.